Lemaitre Vascular Inc income statement

In fiscal 2025, Lemaitre Vascular Inc reported revenue of $250m, up 13.5% on the year before, operating income of $67.9m (a 27.2% margin) and net income of $57.7m, or $2.52 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Lemaitre Vascular Inc: income statement, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	51	56	58	57	65	71	78	89	101	106	117	129	154	162	193	220	250	262
Cost of revenue	—	—	—	—	—	—	—	26	30	32	37	45	53	57	66	69	71	71
Gross profit	37	42	40	41	45	48	54	63	71	74	80	85	101	105	127	151	179	191
Research and development	6	5	4	5	5	5	5	6	7	8	9	10	12	13	17	16	14	15
Selling and marketing	18	19	19	21	22	22	23	26	26	27	30	24	28	33	41	47	54	54
General and administrative	10	11	11	11	13	14	14	14	17	18	19	23	26	29	32	36	42	44
Operating income	2	4	4	4	5	6	12	16	21	28	21	29	36	27	37	52	68	77
Interest expense	0	0	—	0	0	0	—	0	0	0	0	1	2	0	0	0	5	5
Income before tax	2	4	4	4	4	6	11	16	21	28	22	27	34	27	39	57	75	85
Income tax	1	−2	2	1	1	2	4	6	4	6	4	6	7	7	9	13	17	19
Net income	2	6	2	3	3	4	8	11	17	23	18	21	27	21	30	44	58	66
Diluted EPS	$0.10	$0.37	$0.13	$0.16	$0.20	$0.23	$0.42	$0.55	$0.86	$1.13	$0.88	$1.04	$1.25	$0.93	$1.34	$1.93	$2.52	$2.81
Diluted shares (average)	16m	16m	16m	16m	16m	17m	18m	19m	20m	20m	20m	20m	21m	22m	22m	23m	23m	23m
EBITDA	3	5	6	6	7	10	15	20	25	33	27	37	47	36	46	62	78	88

US$ millions unless shown otherwise. Fiscal quarters.

Lemaitre Vascular Inc: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	55	56	60	64	61	64	67	70
Cost of revenue	18	17	18	19	15	18	18	20
Gross profit	37	39	41	45	46	46	48	51
Research and development	4	4	4	4	3	4	4	5
Selling and marketing	11	13	14	15	12	13	15	14
General and administrative	9	9	10	10	11	10	12	11
Operating income	13	13	13	16	20	19	18	20
Interest expense	0	0	1	1	1	1	1	1
Income before tax	15	14	14	18	23	20	20	22
Income tax	3	3	3	4	5	5	4	5
Net income	11	11	11	14	17	16	16	17
Diluted EPS	$0.49	$0.48	$0.48	$0.60	$0.75	$0.68	$0.68	$0.74
EBITDA	16	15	15	19	23	21	20	23

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: KIDS vs LMAT AXGN vs LMAT CERS vs LMAT ESTA vs LMAT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Lemaitre Vascular Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Lemaitre Vascular Inc.